Détail de l'auteur
Auteur H. HAGAN |
Documents disponibles écrits par cet auteur (44)
Article : Périodique
H. HAGAN ; D. C. DES JARLAIS ; D. PURCHASE ; S. R. FRIEDMAN ; T. REID ; T. A. BELL |FRANÇAIS : Nous faisons ici le compte rendu de la mise en oeuvre et de l'efficacité potentielle de la plus longue opération d'échange de seringues fonctionnant aux USA, de même que nous comparons nos résultats à ceux d'études portant sur des p[...]Article : Périodique
Objective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed. Design: Internat[...]Périodique
D. C. DES JARLAIS ; D. PAONE ; MILLIKEN J. ; C. F. TURNER ; H. MILLER ; GRIBBLE J. ; SHI Q. ; H. HAGAN ; S. R. FRIEDMAN | 1999FRANÇAIS : Une méthode d'entretien (audio-CASI) par ordinateur où les questions sont posées sur l'écran et en même temps à l'aide d'un casque audio et les réponses données par sélection sur le clavier, permet de réduire les sous-déclarations. D[...]Article : Périodique
D. C. DES JARLAIS ; H. HAGAN ; K. ARASTEH ; C. McKNIGHT ; S. SEMAAN ; D. C. PERLMAN |BACKGROUND: Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition. METHODS: Subjects were recruited from IDUs entering t[...]Périodique
S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004ENGLISH : Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and pati[...]Article : Périodique
S. M. JENNESS ; H. HAGAN ; K. L. LIU ; T. WENDEL ; C. S. MURRILL |Sterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New Y[...]Article : Périodique
S. DEREN ; H. HAGAN ; S. FRIEDMAN ; D. C. DES JARLAIS ; D. PERLMAN ; M. GWADZ ; C. CLELAND ; A. OSBORNE ; J. LUNIEVICZ |As we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, ther[...]Périodique
T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]Périodique
T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]Article : Périodique
S. M. STRAUSS ; J. ASTONE-TWERELL ; C. E. MUNOZ-PLAZA ; D. C. DES JARLAIS ; M. GWADZ ; H. HAGAN ; A. OSBORNE ; A. ROSENBLUM |BACKGROUND: In spite of the disproportionate prevalence of hepatitis C virus (HCV) infection among drug users, many remain uninformed or misinformed about the virus. Drug treatment programs are important sites of opportunity for providing HCV ed[...]Périodique
C. E. MUNOZ-PLAZA ; S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004ENGLISH : This paper uses qualitative methods to examine both staff and clients perceptions about the delivery of hepatitis C prevention education services at their respective residential drug treatment programs. Through in-depth discussion wi[...]Périodique
J. M. ASTONE TWERELL ; S. M. STRAUSS ; H. HAGAN ; D. C. DES JARLAIS | 2006ENGLISH : Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using da[...]Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Périodique
H. HAGAN ; M. H. LATKA ; J. V. CAMPBELL ; E. T. GOLUB ; R. S. GARFEIN ; D. A. THOMAS ; F. KAPADIA ; S. A. STRATHDEE | 2006ENGLISH : Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depres[...]Livre
Z. SLOBODA ; E. M. ADLAF ; M. D. ANGLIN ; M. L. BRECHT ; J. D. COLLIVER ; K. P. CONWAY ; D. C. DES JARLAIS ; K. W. ELIFSON ; S. R. FRIEDMAN ; C. FRY ; M. D. GLANTZ ; P. GRIFFITHS ; H. HAGAN ; W. HALL ; M. HICKMAN ; Y. I. HSER ; R. L. HUBBARD ; N. J. KOZEL ; T. LOCKE ; D. LONGSHORE ; R. McKETIN ; M. D. NEWCOMB ; J. A. RESKO ; C. E. STERK ; C. TAYLOR ; C. WALKER ; T. A. WILLS | New York : Springer Inc. | 2005ENGLISH : As the drug abuse epidemic evolves, so do the tools needed to understand and treat it. Accordingly, Epidemiology of Drug Abuse takes the long view, cogently outlining what the book calls "the natural history of drug abuse" and redefi[...]Article : Périodique
R. D. BURT ; H. HAGAN ; K. SABIN ; H. THIEDE |PURPOSE: To empirically evaluate respondent-driven sampling (RDS) recruitment methods, which have been proposed as an advantageous means of surveying hidden populations. METHODS: The National HIV Behavioral Surveillance system used RDS to recrui[...]Article : Périodique
D. C. DES JARLAIS ; K. ARASTEH ; J. FEELEMYER ; C. McKNIGHT ; D. M. BARNES ; S. TROSS ; D. C. PERLMAN ; A. N. C. CAMPBELL ; H. L. F. COOPER ; H. HAGAN |Objectives: Transitioning from injecting to non-injecting routes of drug administration can provide important individual and community health benefits. We assessed characteristics of persons who had ceased injecting while continuing to use heroi[...]Périodique
S. M. STRAUSS ; J. ASTONE ; VASSILEV Z. P. ; D. C. DES JARLAIS ; H. HAGAN | 2003ENGLISH : Drug treatment programs are sites of opportunity for the delivery of hepatitis C (HCV) prevention and care services to drug users. Using data collected from a random nationwide sample (N = 595) of drug treatment programs in the Unite[...]Article : Périodique
P. K. NELSON ; B. M. MATHERS ; B. COWIE ; H. HAGAN ; D. C. DES JARLAIS ; D. HORYNIAK ; L. DEGENHARDT |BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population siz[...]Article : Périodique
D. J. SMITH ; J. COMBELLICK ; A. E. JORDAN ; H. HAGAN |Background: Understanding HCV disease progression rates among people who inject drugs (PWID) is important to setting policy to expand access to detection, diagnosis and treatment, and in forecasting the burden of disease. In this paper we synthe[...]Périodique
H. HAGAN | 1998FRANÇAIS : Après une description des caractéristiques du virus de l'hépatite C (VHC), cet article examine les études publiées sur la séroépidémiologie du VHC chez les toxicomanes par injection en relation avec l'épidémiologie du VIH et de l'hép[...]Article : Périodique
DEIBERT R.J. ; GOLDBAUM G. ; T. R. PARKER ; H. HAGAN ; R. MARKS ; HANRAHAN M. ; H. THIEDE |ENGLISH : We examined pharmacists' attitudes and practices related to syringe sales to injection drug users before and after legal reform and local programming to enhance sterile syringe access. We replicated a 1996 study by conducting pharmac[...]Article : Périodique
Aims - We conducted a systematic review of studies reporting seroincidence of hepatitis C infection (HCV) in relation to shared syringes and drug preparation equipment among injection drug users (IDUs). We identified published and unpublished st[...]Article : Périodique
The authors examined the relation between time since onset of illicit drug injection (time at risk) and rates of hepatitis C virus (HCV) infection by using meta-regression. In 72 prevalence studies, median time since onset of injection was 7.24 [...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
M. E. MACKESY-AMITI ; L. FINNEGAN ; L. J. OUELLET ; E. T. GOLUB ; H. HAGAN ; S. M. HUDSON ; M. H. LATKA ; R. S. GARFEIN |We analyzed data from a large randomized HIV/HCV prevention intervention trial with young injection drug users (IDUs) conducted in five U.S. cities. The trial compared a peer education intervention (PEI) with a time-matched, attention control gr[...]Périodique
R. S. GARFEIN ; E. T. GOLUB ; A. E. GREENBERG ; H. HAGAN ; D. L. HANSON ; S. M. HUDSON ; F. KAPADIA ; M. H. LATKA ; L. J. OUELLET ; D. W. PURCELL ; S. A. STRATHDEE ; H. THIEDE | 2007OBJECTIVES: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (I[...]Article : Périodique
AIMS This study conducted a secondary analysis to examine injection cessation and decreasing frequency of injection during a multi-site randomized controlled HIV prevention intervention trial that sought to reduce sexual and injection risk behav[...]Article : Périodique
ENGLISH : Objectives. This study evaluated factors associated with accidental fatal drug overdose among a cohort of injection drug users (IDUs). Methods. In a prospective cohort study of 2849 IDUs in King County, Washington, deaths were identi[...]Chapitre
D. C. DES JARLAIS ; H. HAGAN ; S. R. FRIEDMAN ; P. FRIEDMANN ; D. GOLDBERG ; M. FRISCHER ; S. GREEN ; K. TUNVING ; B. LJUNGBERG ; A. WODAK ; M. ROSS ; D. PURCHASE ; P. MILLSON ; T. MYERS | London : UCL Press | 1998FRANÇAIS : Les auteurs présentent l'historique de l'épidémie VIH dans cinq villes : Glasgow, Lund, Sydney, Tacoma et Toronto. La séroprévalence du VIH-1, dans la communauté des injecteurs hétérosexuels, est restée basse ou stable. Les 5 villes[...]Article : Périodique
Périodique
H. HAGAN ; MAC GOUGH J. P. ; H. THIEDE ; S. HOPKINS ; DUCHIN J. ; E. R. ALEXANDER | 2000FRANÇAIS : Les participants à cette étude (une cohorte dUDVI de Seattle) ont été observés selon quils ont eu recours ou pas, lors du recrutement ou durant les 6 mois de suivi de létude, à un échange de seringues. Les résultats montrent que les [...]Article : Périodique
H. THIEDE ; VALLEROY L. A. ; MACKELLAR D. A. ; D. D. CELENTANO ; W. L. FORD ; H. HAGAN ; KOBLIN B. A. ; M. LALOTA ; W. McFARLAND ; SHEHAN D. A. ; TORIAN L. V. |ENGLISH : Objectives. We sought to characterize substance use patterns in young men who have sex with men (MSM) in 7 US urban areas and sociodemographic characteristics and history associated with such use. Methods. We examined data collected [...]Périodique
S. M. STRAUSS ; J. M. ASTONE ; C. E. MUNOZ-PLAZA ; H. HAGAN ; D. C. DES JARLAIS | 2005ENGLISH : Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examin[...]Article : Périodique
H. HAGAN ; H. THIEDE ; N. S. WEISS |OBJECTIVES: This study investigated the sharing of drug preparation equipment as a possible route of hepatitis C virus (HCV) transmission. METHODS: HCV seroconversion was measured in a cohort of 317 injection drug users who tested negative for [...]Article : Périodique
ENGLISH : Drug users are at risk of acquiring the hepatitis C virus (HCV). Although ancillary services available to clients at drug treatment programs are often limited, some of these programs are providing HCV services. Presenting qualitative[...]Périodique
H. HAGAN ; J. P. McGOUGH ; H. THIEDE ; N. S. WEISS ; S. HOPKINS ; E. R. ALEXANDER | 1999FRANÇAIS : L'étude porte sur une cohorte d'usagers de drogues par voie injectable de Seattle participant à une étude plus large (RAVEN Study - Risk Activity Variables, Epidemiology, and Network Study), et concerne 187 personnes séronégatives au[...]Article : Périodique
FRANÇAIS : Dans le monde entier, les usagers de drogues sont victimes de taux élevés de transmission de l'hépatite C. Ce rapport analyse l'impact des interventions de réduction de risques sur la séro-conversion du virus de l'hépatite C et ident[...]Article : Périodique
BACKGROUND: Genital ulcer disease (GUD), including syphilis, is an important cause of morbidity in low and middle income (LMI) countries and syphilis transmission is associated with HIV transmission. METHODS: We conducted a literature review to [...]Article : Périodique
P. MATEU-GELABERT ; M. VIORST GWADZ ; H. GUARINO ; M. SANDOVAL ; C. M. CLELAND ; A. JORDAN ; H. HAGAN ; H. LUNE ; S. R. FRIEDMAN |This pilot study explores the feasibility and preliminary efficacy of the Staying Safe Intervention, an innovative, strengths-based program to facilitate prevention of infection with the human immunodeficiency virus and with the hepatitis C viru[...]Article : Périodique
D. C. DES JARLAIS ; K. ARASTEH ; C. McKNIGHT ; J. FEELEMYER ; A. N. C. CAMPBELL ; S. TROSS ; H. L. F. COOPER ; H. HAGAN ; D. C. PERLMAN |Background and aims: HIV has reached high prevalence in many non-injecting drug user (NIDU) populations. The aims of this study were to (1) examine the trend in HIV prevalence among non-injecting cocaine and heroin NIDUs in New York City, (2) id[...]Nouveauté